Conferences
9–12 September 2023, Verona, Italy
The 34th IASGO World Congress: WEAVING THE FUTURE
IASGO stands for the International Association of Surgeons, Gastroenterologists and Oncologists. IASGO was founded in 1988, and today, it has more than 1700 members from over 90 countries worldwide.
The mission of this organization is the globalization of medical knowledge and expertise through a well-structured system of continued medical education. IASGO believes that medical knowledge and expertise belong to every human being and that this knowledge must be available beyond discrimination—on individual, institutional or national levels—for every patient fighting for survival from challenging and life-threatening diseases.
We are currently experiencing an era of transition with significant innovations. Exciting scientific and technological advances are changing all areas of our lives. The recent emergency linked to the COVID-19 pandemic has inevitably played the role of an accelerator by increasing society’s focus on health issues. As a result, new technologies and medical therapies are emerging for many diseases.
At the IASGO 2023, we will discuss recent developments in surgical oncology to improve patient care and quality standards. Molecular biology and biotechnology are also revolutionizing medicine. The management of cancers is changing through the characterization of tumor molecular biological profiles using next-generation sequencing. The future of medicine is increasingly taking shape with the latest discoveries in genetics that enable promising new directions in oncological therapies.
Understanding the specific disease in each cancer patient has evoked a paradigm shift in oncology and is now opening new horizons in diagnostics and therapeutics. Progress is being made in the development of molecularly targeted therapy. Precision medicine aims to design and optimize the pathway for early diagnosis, assessing prognosis and tailoring therapeutic interventions. Furthermore, artificial intelligence algorithms can now successfully predict the risk of cancers and gastrointestinal diseases.
Increasingly more evidence suggests that lifestyle plays a fundamental role in well-being and patients’ health. Normal body weight and consistent physical activity prevent gastrointestinal, metabolic and neoplastic diseases and manage their presence. Likewise, proper nutrition counteracts chemotherapy’s side effects and helps toward a faster recovery after surgery, as demonstrated in the ERAS Society guidelines, with which IASGO cooperates.
The newly established IASGO multidisciplinary clinical trial consortium for the treatment of oncological diseases seeks to improve diagnosis and increase treatment feasibility and efficacy. It also aims to make the available treatments more accessible, improve patients’ quality of life and compliance with therapies and follow-up, and thus optimize the use of resources.
Finally, sustainability is becoming increasingly important in medicine and healthcare. Physicians need to be aware of eco-friendly solutions that provide high-quality care to patients while lowering costs and reducing the environmental impact. Prevention, telemedicine counseling, training and expanding healthcare coverage equitably should be the way forward.
For all these reasons and more, please join us at the upcoming IASGO Congress held at the Palazzo Della Gran Guardia in Verona between 9 and 12 September 2023. Verona is a spectacular city, a key part of Italian history, a symbol of art and culture in the world and a recognized UNESCO heritage site. We look forward to seeing you at this celebration of the latest medical and scientific advancements in GI cancer treatment during the IASGO 34th World Congress in the beautiful and traditional city of Verona.
REGISTRATIONS: https://www.iasgoverona.com/registration-travel/
SCIENTIFIC PROGRAM: https://www.iasgoverona.com/program/
